Prestige Consumer Healthcare Inc. (PBH)
NYSE: PBH · Real-Time Price · USD
86.90
+5.49 (6.74%)
May 8, 2025, 2:32 PM - Market open
Revenue by Product
Fiscal year is April - March.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | NaN - NaN |
| North American OTC Healthcare | 942.19M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North American OTC Healthcare Growth | -2.81% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International OTC Healthcare | 176.05M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International OTC Healthcare Growth | 6.83% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Analgesics | 115.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Analgesics Growth | -1.73% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cough & Cold | 105.49M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cough & Cold Growth | -14.34% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Women's Health | 233.22M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Women's Health Growth | -4.17% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Gastrointestinal | 246.70M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Gastrointestinal Growth | 7.07% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Eye & Ear Care | 180.58M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Eye & Ear Care Growth | -1.10% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Dermatologicals | 130.70M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Dermatologicals Growth | 0.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Oral Care | 93.25M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Oral Care Growth | -2.90% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other OTC | 13.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other OTC Growth | 10.36% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Gross Income by Product
Fiscal year is April - March.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | NaN - NaN |
| North American OTC Healthcare Gross Margin | 515.05M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North American OTC Healthcare Gross Margin Growth | 0.30% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International OTC Healthcare Gross Margin | 101.22M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International OTC Healthcare Gross Margin Growth | 9.90% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is April - March.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | NaN - NaN |
| North American OTC Healthcare Contribution Margin | 384.63M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North American OTC Healthcare Contribution Margin Growth | 3.43% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International OTC Healthcare Contribution Margin | 75.41M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International OTC Healthcare Contribution Margin Growth | 6.01% |
Log In |
Log In |
Log In |
Log In | Upgrade
|